Nipro Corporation (TYO:8086)

Nipro Revenue

Nipro had revenue of 167.55B JPY in the quarter ending June 30, 2026, with 5.23% growth. This brings the company's total for the last twelve months to 668.86B, up 2.68% year-over-year. In the fiscal year ending March 31, 2026, Nipro had annual revenue of 660.54B with 2.47% growth. That makes Nipro the 2,936th largest company in the world by revenue and 292nd in Japan.

• Revenue (ttm): 668.86B
• Revenue Growth: +2.68%
• P/S Ratio: 0.34
• Revenue / Employee: 17.33M
• Employees: 38,593
• Market Cap: 224.39B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Related 530.93B 71.6%
• Pharmaceutical related 141.70B 19.1%
• Pharma Packaging 62.01B 8.4%
• Others 7.10B 1.0%

By Geography

Chart

• Japan 309.37B 61.4%
• Asia 101.30B 20.1%
• Europe 50.34B 10.0%
• U.S.A 42.82B 8.5%

Fiscal year ended Mar 31, 2026 See the full Nipro breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	660.54B	15.95B	2.47%
Mar 31, 2025	644.59B	57.80B	9.85%
Mar 31, 2024	586.79B	41.59B	7.63%
Mar 31, 2023	545.20B	50.41B	10.19%
Mar 31, 2022	494.79B	39.23B	8.61%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error